The main cause of aplastic anemia is.

Written by Li Fang Fang
Hematology
Updated on September 15, 2024
00:00
00:00

The causes of aplastic anemia are considered to be of three types: abnormalities in hematopoietic stem cells, abnormalities in the bone marrow microenvironment, and abnormalities in immune factors. Among these, abnormalities in immune factors play a dominant role. Therefore, most patients with aplastic anemia see some improvement after receiving immunosuppressive therapy clinically. However, there is a small subset of patients with aplastic anemia for whom immunosuppressive therapy is not effective, and the causes of the disease in these patients are not well understood and may be congenital, such as congenital dyskeratosis.

Other Voices

doctor image
home-news-image
Written by Li Fang Fang
Hematology
1min 3sec home-news-image

What are the symptoms of aplastic anemia?

The symptoms of aplastic anemia include three main symptoms: firstly, infections; secondly, anemia; and thirdly, bleeding. Infections occur due to a decrease in white blood cells, especially neutrophils, resulting in poor resistance in patients making them susceptible to subsequent infections, including infections of the lungs, digestive system, urinary system, and skin and mucous membranes. Anemia occurs due to a reduction in red blood cells, causing symptoms such as dizziness, headaches, fatigue, reduced tolerance to physical activity, and poor appetite. A reduction in platelets significantly increases the risk of bleeding, especially when platelets are less than 20 times 10 to the ninth power per liter, which can lead to bleeding in the skin, mucous membranes, organs, and even cerebral hemorrhage.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
45sec home-news-image

What causes aplastic anemia?

Aplastic anemia's exact causes are still not completely clear. Clinically, it is believed that immune dysfunction is a significant factor associated with aplastic anemia. Most cases of aplastic anemia can achieve good therapeutic outcomes through immunosuppressive treatment, which indirectly supports this view. However, some scholars believe that in aplastic anemia, there are patients for whom immunosuppressive treatment is ineffective. This suggests that other factors might exist, such as congenital anomalies in hematopoietic stem and progenitor cells, or abnormalities in the hematopoietic microenvironment, which may also play a role in the development of aplastic anemia.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
59sec home-news-image

Which is more severe, aplastic anemia or leukemia?

Aplastic anemia is not leukemia. Leukemia is characterized by more than 20% primary cells in the bone marrow being classified as leukemia. Aplastic anemia, on the other hand, is a bone marrow failure disease, characterized by a reduction in hematopoietic cells in the bone marrow, leading to a decrease in all blood cells. Aplastic anemia can be divided into acute aplastic anemia and chronic aplastic anemia. Acute aplastic anemia has a rapid onset, severe condition, and high mortality rate, while chronic aplastic anemia has a slow onset, longer disease history, and lower mortality rate. Treatment for acute aplastic anemia requires intensified immunotherapy or syngeneic complete match transplantation, whereas treatment for chronic aplastic anemia mainly involves promotive hematopoietic therapy.

doctor image
home-news-image
Written by Zhang Xiao Le
Hematology
1min 13sec home-news-image

Are the liver and kidney functions normal in patients with aplastic anemia?

Patients with aplastic anemia generally have normal liver and kidney functions. However, in certain special circumstances, abnormalities in liver and kidney functions may occur, including: Firstly, the routine treatment for aplastic anemia mainly includes the immunosuppressant cyclosporine and the hematopoietic stimulant androgens. The primary side effect of cyclosporine is renal toxicity. Therefore, during the use of cyclosporine, it is necessary to monitor the concentration of cyclosporine; excessive levels can lead to renal dysfunction. Androgens, including stanozolol and danazol, primarily cause hepatic toxicity; hence, it is necessary to monitor liver and kidney functions during treatment of aplastic anemia. The second factor that may cause liver and kidney function abnormalities is severe anemia. Long-term severe anemia can lead to tissue ischemia and hypoxia in the liver or kidneys, and if prolonged, it can cause abnormalities in liver and kidney functions. (Medication use should be carried out under the guidance of a physician.)

doctor image
home-news-image
Written by Li Fang Fang
Hematology
46sec home-news-image

Is aplastic anemia leukemia?

Aplastic anemia is not leukemia, but there is a very small chance that aplastic anemia can transform into leukemia. Aplastic anemia is a bone marrow failure syndrome, and its clinical presentation often includes pancytopenia. It can be classified into acute aplastic anemia and chronic aplastic anemia. Leukemia often manifests with high white blood cell counts, anemia, and low platelet counts. It is caused by the infiltration of leukemia cells into the bone marrow, leading to the suppression of normal hematopoiesis, and is classified as a malignant hematological tumor. Leukemia can be divided into acute leukemia and chronic leukemia.